P-185 A Prospective, Randomized, Controlled, Multicenter Phase III Clinical Trial of Apatinib Combined with Neoadjuvant Chemoradiotherapy for Patients with Locally Advanced, HER2-negative, Siewert’s Type II-III Adenocarcinoma of Esophagogastric Junction
ANNALS OF ONCOLOGY（2021）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined